What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2026-06-29 compared with 2025-06-30 · 16 added, 42 removed, 3 unchanged (95% of the section changed)

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchasers of Equity Securities

Common Stock is currently quoted on the Nasdaq under the symbol “ATXG.”

in stocks quoted on the Nasdaq is often thin and is characterized by wide fluctuations in trading prices due to many factors that may

have little to do with a company’s operations or business prospects.

We cannot assure you that there will be a market for our common

stock in the future.

received our trading symbol on September 12, 2016 and were first quoted on September 12, 2016 but no shares were traded until December

of Our Common Stock

shares of Common Stock were issued and outstanding as of June 29, 2025.

They were held by a total of 453 shareholders of record.

holders of Common Stock are entitled to one vote for each share held of record on all matters submitted to a vote of stockholders.

of Common Stock have no preemptive rights and no right to convert their Common Stock into any other securities.

There is no redemption

or sinking fund provisions applicable to the Common Stock.

transfer agent for the Common Stock is Transfer Online, Inc.

The transfer agent’s address is 512 SE Salmon St., Portland, OR 97214,

and its telephone number is +1 (503) 227-2950.

cash dividends were paid on our shares of Common Stock during the fiscal year ended March 31, 2025 and March 31, 2024.

We have not paid

any cash dividends since October 28, 2014 (inception) and do not foresee declaring any cash dividends on our common stock in the foreseeable

Common Stock is currently traded on the Nasdaq Capital Market under the symbol “ATXG.”

of June 29, 2026, there were 1,031,435 shares of Common Stock issued and outstanding held by a total of 428 shareholders of record, not

including beneficial holders whose shares are held in names other than their own.

have not paid any cash dividends on our Common Stock, and our board of directors currently intends to retain future earnings, if any,

to fund the operations and growth of our business.

Any determination by our board of directors to pay dividends in the future to stockholders

will be dependent upon our operational results, financial condition, capital requirements, business projections, general business conditions,

statutory and regulatory restrictions, and any other factors deemed appropriate by our board of directors.

addition, our ability to pay dividends may be subject to restrictions under applicable PRC laws and regulations and the ability of our

subsidiaries to distribute funds to us.

Business — Transfers of Cash to and from our Subsidiaries.”

Authorized for Issuance under Equity Compensation Plans

May 28, 2024, our Board adopted our 2024 Equity Incentive Plan (the “2024 Equity Incentive Plan”), which was approved by

our shareholders at our annual shareholders meeting on June 28, 2024.

The 2024 Equity Incentive Plan gives us the ability to grant stock

options, stock appreciation rights (SARs), restricted stock and other stock-based awards to officers, directors (including independent

directors), employees or consultants of our company or of any subsidiary of our company and to non-employee members of our advisory board

or our Board or the board of directors of any of our subsidiaries.

The shares covered by the 2024 Equity Incentive Plan are 1,345,000

of June 29, 2025, there were no outstanding options to purchase any shares of common stock granted under the Plans.

Options granted in

the future under the Plans are within the discretion of our Board or our compensation committee.

For information on securities authorized for issuance under our existing equity compensation plan, see Item 12 under

the heading “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.”

Sales of Unregistered Securities

claim an exemption from registration pursuant to Section 4(a)(2) and/or Rule 506(b) of Regulation D of the Securities Act, and the rules

and regulations promulgated thereunder in connection with the sales and issuances described above since the foregoing issuances and sales

did not involve a public offering, the recipients were (a) “ accredited investors ”, and/or (b) had access to similar

documentation and information as would be required in a Registration Statement under the Securities Act.

With respect to the transactions

described above, no general solicitation was made either by us or by any person acting on our behalf.

The transactions were privately

negotiated, and did not involve any kind of public solicitation.

No underwriters or agents were involved in the foregoing issuances and

we paid no underwriting discounts or commissions.

The securities sold are subject to transfer restrictions, and the certificates evidencing

the securities contain an appropriate legend stating that such securities have not been registered under the Securities Act and may not

be offered or sold absent registration or pursuant to an exemption therefrom.

the fiscal year ended March 31, 2026, there were no sales of unregistered securities that were required to be reported pursuant to Item

701 of Regulation S-K and that were not previously disclosed in a Current Report on Form 8-K or Quarterly Report on Form 10-Q.

Purchases of Equity Securities

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity